Product
CKD-391(2)
1 clinical trial
1 indication
Indication
DyslipidemiaClinical trial
A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391(2) and Co-administration of CKD-331 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2024-01-07